Kinase inhibitor compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S414000, C544S144000, C548S465000

Reexamination Certificate

active

08039470

ABSTRACT:
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.

REFERENCES:
patent: 2003/0069297 (2003-04-01), Cui et al.
patent: 2003/0125370 (2003-07-01), Cui et al.
patent: 2005/0090541 (2005-04-01), Arnaiz et al.
patent: 2006/0287381 (2006-12-01), Liang et al.
patent: 2007/0072934 (2007-03-01), Liang et al.
patent: 2008/0221132 (2008-09-01), Cai et al.
patent: WO-0160814 (2001-08-01), None
patent: 0202551 (2002-01-01), None
patent: WO-0296361 (2002-02-01), None
patent: WO-02055517 (2002-07-01), None
patent: 02066463 (2002-08-01), None
patent: 03031438 (2003-04-01), None
patent: 2005053686 (2005-06-01), None
patent: 2005058309 (2005-06-01), None
patent: 2006052936 (2006-05-01), None
patent: 2006127961 (2006-11-01), None
patent: 2007085205 (2007-02-01), None
patent: 2007081560 (2007-07-01), None
patent: 2008033743 (2008-03-01), None
patent: WO-2008033747 (2008-03-01), None
Lala et al., Role of nitric oxide in tumor progression: Lessons from experimental tumors, Cancer and Metastasis Reviews (1998), 17, 91-106.
Golub et al., Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science (1999), vol. 286, 531-537.
Vippagunta et al., Crystalline solids, 2001, Advanced Drug Delivery Reviews, 48, 3-26.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Kinase inhibitor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kinase inhibitor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitor compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4282672

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.